Wolfgang Wick

95.2k total citations · 26 hit papers
631 papers, 42.2k citations indexed

About

Wolfgang Wick is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wolfgang Wick has authored 631 papers receiving a total of 42.2k indexed citations (citations by other indexed papers that have themselves been cited), including 419 papers in Genetics, 174 papers in Pulmonary and Respiratory Medicine and 166 papers in Molecular Biology. Recurrent topics in Wolfgang Wick's work include Glioma Diagnosis and Treatment (410 papers), Brain Metastases and Treatment (127 papers) and Radiomics and Machine Learning in Medical Imaging (66 papers). Wolfgang Wick is often cited by papers focused on Glioma Diagnosis and Treatment (410 papers), Brain Metastases and Treatment (127 papers) and Radiomics and Machine Learning in Medical Imaging (66 papers). Wolfgang Wick collaborates with scholars based in Germany, Switzerland and United States. Wolfgang Wick's co-authors include Michael Weller, Michael Platten, Roger Stupp, Andreas von Deimling, Guido Reifenberger, Martin Bendszus, Martin J. van den Bent, Timothy F. Cloughesy, Felix Sahm and Alexander Radbruch and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Wolfgang Wick

600 papers receiving 41.6k citations

Hit Papers

Updated Response Assessment Criteria for High-Grade Gliom... 2002 2026 2010 2018 2010 2014 2011 2009 2015 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
    2010 2.7k citations Patrick Y. Wen, Timothy F. Cloughesy et al. Journal of Clinical Oncology profile →
  2. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
    2014 1.8k citations Olivier Chinot, Wolfgang Wick et al. profile →
  3. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
    2011 1.4k citations Christiane A. Opitz, Felix Sahm et al. profile →
  4. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
    2009 868 citations Christian Hartmann, Jörg Felsberg et al. profile →
  5. Glioma
    2015 792 citations Michael Weller, Wolfgang Wick et al. profile →
  6. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
    2012 769 citations Wolfgang Wick, Michael Platten et al. profile →
  7. Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
    2008 658 citations Wolfgang Wick, Michael Weller et al. Journal of Clinical Oncology profile →
  8. How to use and assess qualitative research methods
    2020 633 citations Wolfgang Wick et al. profile →
  9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
    2010 627 citations Christian Hartmann, Bettina Hentschel et al. profile →
  10. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
    2002 605 citations Wolfgang Wick, Michael Weller et al. profile →
  11. Standards of care for treatment of recurrent glioblastoma—are we there yet?
    2012 587 citations Michael Weller, Timothy F. Cloughesy et al. Neuro-Oncology profile →
  12. MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
    2009 575 citations Michael Weller, Guido Reifenberger et al. profile →
  13. NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
    2009 571 citations Wolfgang Wick, Christian Hartmann et al. Journal of Clinical Oncology profile →
  14. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
    2014 568 citations Michael Weller, Martin J. van den Bent et al. profile →
  15. Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
    2008 566 citations Wolfgang Wick et al. Journal of Clinical Oncology profile →
  16. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 565 citations Wolfgang Wick et al. Annals of Oncology profile →
  17. Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
    2012 554 citations Michael Platten, Wolfgang Wick et al. Cancer Research profile →
  18. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
    2015 471 citations Michael Weller, Wolfgang Wick et al. profile →
  19. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
    2014 445 citations Anna S. Berghoff, Michael Weller et al. Neuro-Oncology profile →
  20. Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent
    2015 432 citations Alexander Radbruch, Philipp Kickingereder et al. profile →
  21. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
    2017 426 citations Michael Weller, Martin J. van den Bent et al. Annals of Oncology profile →
  22. MGMT testing—the challenges for biomarker-based glioma treatment
    2014 393 citations Wolfgang Wick, Michael Weller et al. profile →
  23. Automated brain extraction of multisequence MRI using artificial neural networks
    2019 364 citations David Bonekamp, Ulf Neuberger et al. profile →
  24. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models
    2016 321 citations Philipp Kickingereder, Antje Wick et al. profile →
  25. Cancer neuroscience: State of the field, emerging directions
    2023 243 citations Frank Winkler, Michael Platten et al. profile →
  26. EANO guideline on the diagnosis and treatment of vestibular schwannoma
    2019 230 citations Michael Weller, Wolfgang Wick et al. Neuro-Oncology profile →

Peers

Wolfgang Wick
David A. Reardon United States
Patrick Y. Wen United States
Timothy F. Cloughesy United States
Alba A. Brandes Italy
Jill S. Barnholtz‐Sloan United States
Roger Stupp Switzerland
J. Gregory Cairncross Canada
Thierry Gorlia Belgium
Warren Mason Canada
Guido Reifenberger Germany
David A. Reardon United States
Wolfgang Wick
Citations per year, relative to Wolfgang Wick Wolfgang Wick (= 1×) peers David A. Reardon

Countries citing papers authored by Wolfgang Wick

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Wick more than expected).

Fields of papers citing papers by Wolfgang Wick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Wick. The network helps show where Wolfgang Wick may publish in the future.

Co-authorship network of co-authors of Wolfgang Wick

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Wick. A scholar is included among the top collaborators of Wolfgang Wick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Wick. Wolfgang Wick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burghaus, Ina, Tobias Keßler, Felix Sahm, et al.. (2024). PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. BMC Cancer. 24(1). 135–135. 26 indexed citations
2.
Bent, Martin J. van den, Ingo K. Mellinghoff, Mehdi Touat, et al.. (2024). 10311- ACT-19 A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS. Neuro-Oncology Advances. 6(Supplement_4). iv9–iv9. 2 indexed citations
3.
Wick, Wolfgang, Antje Wick, Inga Harting, et al.. (2024). CTNI-85. FINAL RESULTS FROM N2M2/NOA-20. Neuro-Oncology. 26(Supplement_8). viii117–viii117.
4.
Ippen, Franziska M., Thomas Hielscher, Asmita Patel, et al.. (2024). 482P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma: Insights of a multicenter analysis. Annals of Oncology. 35. S421–S421.
5.
Mellinghoff, Ingo K., Martin J. van den Bent, Deborah T. Blumenthal, et al.. (2023). KS02.6.A INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE III STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION. Neuro-Oncology. 25(Supplement_2). ii4–ii5.
6.
Kickingereder, Philipp, Michael Götz, John Muschelli, et al.. (2016). Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response. Clinical Cancer Research. 22(23). 5765–5771. 206 indexed citations
7.
Osswald, Matthias, Jonas Blaes, Yunxiang Liao, et al.. (2016). Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases. Clinical Cancer Research. 22(24). 6078–6087. 88 indexed citations
8.
Ilhan‐Mutlu, Aysegül, Matthias Osswald, Yunxiang Liao, et al.. (2016). Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma. Molecular Cancer Therapeutics. 15(4). 702–710. 86 indexed citations
9.
Sandmann, Thomas, Richard Bourgon, Josep Garcia, et al.. (2015). Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. Journal of Clinical Oncology. 33(25). 2735–2744. 208 indexed citations
10.
Wick, Wolfgang, Harald Fricke, Klaus Junge, et al.. (2014). A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma. Clinical Cancer Research. 20(24). 6304–6313. 95 indexed citations
11.
Sahm, Felix, Iris Oezen, Christiane A. Opitz, et al.. (2013). The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress. Cancer Research. 73(11). 3225–3234. 131 indexed citations
12.
Wick, Wolfgang, Christoph Meisner, Bettina Hentschel, et al.. (2013). Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology. 81(17). 1515–1522. 173 indexed citations
13.
Lemke, Dieter, Felix Sahm, Tore Kempf, et al.. (2011). Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness. Clinical Cancer Research. 18(1). 105–117. 118 indexed citations
14.
Wick, Wolfgang, Vinay K. Puduvalli, Marc C. Chamberlain, et al.. (2010). Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma. Journal of Clinical Oncology. 28(7). 1168–1174. 359 indexed citations
15.
Wick, Wolfgang, Christian Hartmann, Corinna Engel, et al.. (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology. 27(35). 5874–5880. 571 indexed citations breakdown →
16.
Platten, Michael, Wolfgang Wick, & Michael Weller. (2001). Malignant glioma biology: Role for TGF-? in growth, motility, angiogenesis, and immune escape. Microscopy Research and Technique. 52(4). 401–410. 201 indexed citations
17.
Beales, Derek, Wolfgang Wick, G. R. Elton, et al.. (1978). HIS volume 21 issue 3 Front matter. The Historical Journal. 21(3). f1–f6. 1 indexed citations
18.
Beales, Derek, Wolfgang Wick, G. R. Elton, et al.. (1978). HIS volume 21 issue 2 Front matter. The Historical Journal. 21(2). f1–f6. 1 indexed citations
19.
Beales, Derek, Wolfgang Wick, G. R. Elton, et al.. (1978). HIS volume 21 issue 4 Front matter. The Historical Journal. 21(4). f1–f6. 1 indexed citations
20.
Beales, Derek, Wolfgang Wick, G. R. Elton, et al.. (1978). HIS volume 21 issue 1 Cover and Front matter. The Historical Journal. 21(1). f1–f6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Reardon Breakdown of academic impact, for papers by Patrick Y. Wen Breakdown of academic impact, for papers by Timothy F. Cloughesy Breakdown of academic impact, for papers by Alba A. Brandes Breakdown of academic impact, for papers by Jill S. Barnholtz‐Sloan Breakdown of academic impact, for papers by Roger Stupp Breakdown of academic impact, for papers by J. Gregory Cairncross Breakdown of academic impact, for papers by Thierry Gorlia Breakdown of academic impact, for papers by Warren Mason Breakdown of academic impact, for papers by Guido Reifenberger
Rankless by CCL
2026